Latest News

Friday, August 28, 2015 | Medical Studies

Fixed-Combination Therapy Statistically Superior to Its Active Components

The fixed-dose combination of AR-13324 0.02% and latanoprost 0.005% in PG324 ophthalmic solution (PG324 [Roclatan]; Aerie Pharmaceuticals) provides clinically and statistically superior ocular hypoten…

Read the full story

Friday, August 28, 2015 | Medical Studies

Antibiotic Use Linked to Increased Risk for Type 2 Diabetes

Antibiotic use was associated with an increased risk for type 2 diabetes in a new population-based, case-control study. The findings were published online August 27, 2015 in the Journal of Clinical En…

Read the full story

Thursday, August 27, 2015 | Corporate Lawsuits

Contact Lens Makers Taking Fight Over Price Law to Court

A legal battle over a hotly contested Utah law banning minimum prices for contact lenses is set to come before a federal appeals court on Thursday. The nation's largest contact lens companies are …

Read the full story

Thursday, August 27, 2015 | Product Releases, Ellex

Ellex to Show Proprietary Retinal Rejuvenation Therapy at ESCRS

Ellex Medical Lasers will showcase its proprietary Retinal Rejuvenation Therapy (2RT) laser at the upcoming European Society of Cataract and Refractive Surgeons (ESCRS) meeting in Barcelona, Spain, Se…

Read the full story

Thursday, August 27, 2015 | Acquisitions/Mergers, InSite Vision, QLT

InSite Vision and QLT Amend Merger Agreement

InSite Vision announced that InSite and QLT entered into a revised merger agreement under which QLT will acquire InSite Vision. Under the terms of the revised merger agreement, a wholly owned subsidia…

Read the full story

Wednesday, August 26, 2015 | Cataract Surgery

International Standards Proposed for Cataract Surgery

A proposed new registry for cataract surgery data would allow physicians and researchers to compare outcomes from diverse countries around the world, its authors say. However, the American Academy of …

Read the full story

Wednesday, August 26, 2015 | Partnerships, Heidelberg Engineering

Swept-Source OCT: Patent License Agreement between Massachusetts General Hospital and Heidelberg Engineering

Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applic…

Read the full story

Wednesday, August 26, 2015 | Conferences, Glaukos Corporation

Glaukos to be Featured in Nine Podium and Poster Presentations at ESCRS

Glaukos announced that its products will be featured in nine key opinion leader presentations at the XXXIII Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) in Barcelona, S…

Read the full story

Tuesday, August 25, 2015 | Clinical Trials

Lenstec Begins FDA Trials of Implantable Bi-focal Quarter Diopter IOL

Lenstec announced the start of an FDA trial in support of gaining FDA clearance for its segmented bi-focal lens (SBL-3), according to a company news release. The SBL-3 is designed to provide near, int…

Read the full story

Tuesday, August 25, 2015 | Recalls, Allergan

Allergan Issues Voluntary Nationwide Recall In The US Of Specific Lots Of Eye Products

Allergan announced that it is conducting a voluntary recall down to consumer level of specific lots of its Refresh Lacri-Lube 3.5g and 7g for dry eye, Refresh PM 3.5g for dry eye, FML (fluorometholone…

Read the full story

Tuesday, August 25, 2015 | Product Releases, Abbott Medical Optics, AMO

Abbott Launches Three New Cylinder Powers for its Tecnis Toric 1-Piece Lens

Abbott announced the FDA approval and launch of three new cylinder powers (4.50 D, 5.25 D, and 6.00 D) for its Tecnis Toric IOL. These new IOLs are indicated for those with cataracts who have a signif…

Read the full story

Tuesday, August 25, 2015 | FDA Approval/Clearance, RetroSense Therapeutics

RetroSense Therapeutics’ Lead Gene Therapy Candidate Gets FDA Clearance to Proceed to First-in-Human Clinical Trials

RetroSense Therapeutics announced that the company’s investigational new drug (IND) application for RST-001 received FDA clearance for the treatment of retinitis pigmentosa, according to a compa…

Read the full story

Tuesday, August 25, 2015 | Medical Studies

Gut Microbes Activate T Cells Causing Autoimmune Eye Disease

Commensal microbes in the gut can activate retina-specific T cells that go on to cause autoimmune uveitis in a mouse model, researchers report. "These findings allow us to understand the biologic…

Read the full story

Monday, August 24, 2015 | Earnings & Financials, TxCell

TxCell Granted 1.28 Million Euro for TRUST Project For development of Col-Treg for Autoimmune Uveitis Treatment

TxCell announced that the French government’s Unique Interministerial Fund (FUI) has granted 1.28 million euro to the TRUST project, according to a company news release. The FUI panel awarded th…

Read the full story

Monday, August 24, 2015 | Medical Studies

FDA Warns About Safety Risks for Ingenol Mebutate (Picato)

The US Food and Drug Administration (FDA) has received reports of severe allergic reactions and herpes zoster in patients with actinic keratosis treated with ingenol mebutate (Picato, LEO Pharma) gel,…

Read the full story
Load More
 Stock Price  Change 
 Actavis $298.98  0.00% 
 Aerie Pharmaceuticals, Inc. $16.63  0.79% 
 Akorn, Inc. $41.34  0.32% 
 Alimera Sciences, Inc. $3.45  2.37% 
 Avalanche Biotechnologies $10.83  1.50% 
 Bayer $135.40  -1.67% 
 Can-Fite Biopharma $1.72  6.83% 
 Carl Zeiss Meditec $23.32  -2.43% 
 Cooper Companies, Inc. $163.65  -0.34% 
 Eleven Biotherapeutics $3.45  -4.92% 
 Escalon Medical Corp. $1.30  0.00% 
 Essilor International $120.70  0.00% 
 Imprimis Pharmaceuticals, Inc. $7.59  -1.30% 
 InSite Vision, Inc. $0.26  0.00% 
 IRIDEX Corporation $6.83  1.64% 
 Johnson & Johnson $95.46  -0.79% 
 Luxottica Group, S.p.A. $67.70  -2.13% 
 Merck & Company, Inc. $55.19  0.44% 
 NicOx $1.92  0.52% 
 NovaBay Pharmaceuticals, Inc. $0.38  -2.26% 
 Novartis AG Common Stock $97.93  -0.72% 
 Ocular Therapeutix $17.13  -0.93% 
 Ophthotech Corporation $45.09  -0.51% 
 QLT $3.41  -1.16% 
 Quantel $2.79  0.72% 
 Regeneron $536.05  -0.36% 
 Roche $34.07  -2.24% 
 Second Sight Medical Products $9.44  3.85% 
 STAAR Surgical Company $8.08  0.25% 
 TearLab Corporation $2.66  0.76% 
 Thrombogenics $4.33  0.00% 
 Topcon Corporation $18.45  0.00% 
 Valeant Pharmaceuticals $235.84  0.40% 
 Xoma $0.82  -0.34%